Clearside Biomedical
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $306 | $1,038 | $90 | $230 |
Gross Profit | 157 | 1,038 | 90 | 202 |
EBITDA | -4,648 | -5,156 | -5,210 | -9,332 |
EBIT | -4,727 | -5,231 | -5,254 | -9,360 |
Net Income | -7,306 | -7,688 | -7,594 | -11,763 |
Net Change In Cash | 306 | 1,038 | 90 | 230 |
Free Cash Flow | -5,698 | -5,966 | -6,103 | -7,908 |
Cash | 20,020 | 13,888 | 18,238 | 35,355 |
Basic Shares | 74,274 | 74,745 | 74,731 | 69,853 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,664 | $8,226 | $1,327 | $29,575 |
Gross Profit | 1,515 | 7,871 | 1,123 | 29,397 |
EBITDA | -24,347 | -23,058 | -29,463 | -449 |
EBIT | -24,573 | -23,125 | -29,608 | -627 |
Net Income | -34,352 | -32,485 | -34,071 | 376 |
Net Change In Cash | 1,664 | 8,226 | 1,327 | 29,575 |
Cost of Revenue | 17,722 | 13,049 | ||
Free Cash Flow | -24,698 | -19,912 | -13,611 | -10,733 |
Cash | 20,020 | 28,920 | 48,258 | 30,436 |
Basic Shares | 73,803 | 61,806 | 60,204 | 59,906 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.10 |
2024-09-30 | -$0.10 |
2024-06-30 | -$0.10 |
2024-03-31 | -$0.15 |
